APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gamma-Aminobutyric Acid Receptor Subunit Gamma 2

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Outlook and Growth Opportunities 2026

19 December 2025194 pages

Choose your research edition.

Industry ResearchGamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market include Takeda, Jiangsu Hengrui Medicine Co Ltd, Jiangsu Nhwa Pharmaceutical Corp Ltd, Pfizer Inc, Primex Pharmaceuticals Oy and Paion AG, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market.

Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Segment by Company

Takeda

Jiangsu Hengrui Medicine Co Ltd

Jiangsu Nhwa Pharmaceutical Corp Ltd

Pfizer Inc

Primex Pharmaceuticals Oy

Paion AG

Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Segment by Type

EL-001

Midazolam Hydrochloride

LASSBio-786

LASSBio-785

Others

Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Segment by Application

Insomnia

General Anesthetic Effect

Hypertension

Others

Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 key companies, revenue, market share, and recent developments.

3. To split the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 significant trends, drivers, influence factors in global and regions.

6. To analyze Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 industry.

Chapter 3: Detailed analysis of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Trends Table 2. Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Drivers Table 3. Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Opportunities and Challenges Table 4. Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Restraints Table 5. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue Share by Company (2021-2026) Table 7. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Key Company Manufacturing Base & Headquarters Table 9. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Company, Product Type & Application Table 10. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of EL-001 Table 15. Significant Companies of Midazolam Hydrochloride Table 16. Significant Companies of LASSBio-786 Table 17. Significant Companies of LASSBio-785 Table 18. Significant Companies of Others Table 19. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type (2021-2026) Table 23. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Insomnia Table 25. Significant Companies of General Anesthetic Effect Table 26. Significant Companies of Hypertension Table 27. Significant Companies of Others Table 28. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application (2021-2026) Table 32. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application (2027-2032) Table 33. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Region (2021-2026) Table 36. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Region (2027-2032) Table 38. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Market Share by Country (2021-2026) Table 41. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Market Share by Country (2027-2032) Table 43. Takeda Company Information Table 44. Takeda Business Overview Table 45. Takeda Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Takeda Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio Table 47. Takeda Recent Development Table 48. Jiangsu Hengrui Medicine Co Ltd Company Information Table 49. Jiangsu Hengrui Medicine Co Ltd Business Overview Table 50. Jiangsu Hengrui Medicine Co Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Jiangsu Hengrui Medicine Co Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio Table 52. Jiangsu Hengrui Medicine Co Ltd Recent Development Table 53. Jiangsu Nhwa Pharmaceutical Corp Ltd Company Information Table 54. Jiangsu Nhwa Pharmaceutical Corp Ltd Business Overview Table 55. Jiangsu Nhwa Pharmaceutical Corp Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Jiangsu Nhwa Pharmaceutical Corp Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio Table 57. Jiangsu Nhwa Pharmaceutical Corp Ltd Recent Development Table 58. Pfizer Inc Company Information Table 59. Pfizer Inc Business Overview Table 60. Pfizer Inc Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Pfizer Inc Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio Table 62. Pfizer Inc Recent Development Table 63. Primex Pharmaceuticals Oy Company Information Table 64. Primex Pharmaceuticals Oy Business Overview Table 65. Primex Pharmaceuticals Oy Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Primex Pharmaceuticals Oy Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio Table 67. Primex Pharmaceuticals Oy Recent Development Table 68. Paion AG Company Information Table 69. Paion AG Business Overview Table 70. Paion AG Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Paion AG Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio Table 72. Paion AG Recent Development Table 73. Research Programs/Design for This Report Table 74. Authors List of This Report Table 75. Secondary Sources Table 76. Primary Sources List of Figures Figure 1. Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Image Figure 2. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size (2021-2032) & (US$ Million) Figure 4. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. EL-001 Image Figure 8. Midazolam Hydrochloride Image Figure 9. LASSBio-786 Image Figure 10. LASSBio-785 Image Figure 11. Others Image Figure 12. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type (2021-2032) Figure 15. Insomnia Image Figure 16. General Anesthetic Effect Image Figure 17. Hypertension Image Figure 18. Others Image Figure 19. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application (2021-2032) Figure 22. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value (2021-2032) & (US$ Million) Figure 25. North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value (2021-2032) & (US$ Million) Figure 31. South America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • EL-001
  • Midazolam Hydrochloride
  • LASSBio-786
  • LASSBio-785
  • Others
Applications
  • Insomnia
  • General Anesthetic Effect
  • Hypertension
  • Others
Companies covered
  • Takeda
  • Jiangsu Hengrui Medicine Co Ltd
  • Jiangsu Nhwa Pharmaceutical Corp Ltd
  • Pfizer Inc
  • Primex Pharmaceuticals Oy
  • Paion AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Dynamics
  1. 2.1 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Trends
  2. 2.2 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Drivers
  3. 2.3 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Opportunities and Challenges
  4. 2.4 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Restraints
3 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market by Company
  1. 3.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Company Revenue Ranking in 2025
  2. 3.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Company (2021-2026)
  3. 3.3 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Company Ranking (2024-2026)
  4. 3.4 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Company Manufacturing Base and Headquarters
  5. 3.5 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Company Product Type and Application
  6. 3.6 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market by Type
  1. 4.1 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Type Introduction
  2. 4.1.1 EL-001
  3. 4.1.2 Midazolam Hydrochloride
  4. 4.1.3 LASSBio-786
  5. 4.1.4 LASSBio-785
  6. 4.1.5 Others
  7. 4.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value by Type
  8. 4.2.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value by Type (2021-2032)
  10. 4.2.3 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type (2021-2032)
5 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market by Application
  1. 5.1 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Application Introduction
  2. 5.1.1 Insomnia
  3. 5.1.2 General Anesthetic Effect
  4. 5.1.3 Hypertension
  5. 5.1.4 Others
  6. 5.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value by Application
  7. 5.2.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value by Application (2021-2032)
  9. 5.2.3 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application (2021-2032)
6 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Regional Value Analysis
  1. 6.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value by Region (2021-2032)
  3. 6.2.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value by Region: 2021-2026
  4. 6.2.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value (2021-2032)
  7. 6.3.2 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value (2021-2032)
  10. 6.4.2 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value (2021-2032)
  16. 6.6.2 South America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Country, 2025 VS 2032
7 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Country-level Value Analysis
  1. 7.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value by Country (2021-2032)
  3. 7.2.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value by Country (2021-2026)
  4. 7.2.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Jiangsu Hengrui Medicine Co Ltd
  8. 8.2.1 Jiangsu Hengrui Medicine Co Ltd Company Information
  9. 8.2.2 Jiangsu Hengrui Medicine Co Ltd Business Overview
  10. 8.2.3 Jiangsu Hengrui Medicine Co Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Jiangsu Hengrui Medicine Co Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio
  12. 8.2.5 Jiangsu Hengrui Medicine Co Ltd Recent Developments
  13. 8.3 Jiangsu Nhwa Pharmaceutical Corp Ltd
  14. 8.3.1 Jiangsu Nhwa Pharmaceutical Corp Ltd Company Information
  15. 8.3.2 Jiangsu Nhwa Pharmaceutical Corp Ltd Business Overview
  16. 8.3.3 Jiangsu Nhwa Pharmaceutical Corp Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Jiangsu Nhwa Pharmaceutical Corp Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio
  18. 8.3.5 Jiangsu Nhwa Pharmaceutical Corp Ltd Recent Developments
  19. 8.4 Pfizer Inc
  20. 8.4.1 Pfizer Inc Company Information
  21. 8.4.2 Pfizer Inc Business Overview
  22. 8.4.3 Pfizer Inc Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Inc Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio
  24. 8.4.5 Pfizer Inc Recent Developments
  25. 8.5 Primex Pharmaceuticals Oy
  26. 8.5.1 Primex Pharmaceuticals Oy Company Information
  27. 8.5.2 Primex Pharmaceuticals Oy Business Overview
  28. 8.5.3 Primex Pharmaceuticals Oy Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Primex Pharmaceuticals Oy Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio
  30. 8.5.5 Primex Pharmaceuticals Oy Recent Developments
  31. 8.6 Paion AG
  32. 8.6.1 Paion AG Company Information
  33. 8.6.2 Paion AG Business Overview
  34. 8.6.3 Paion AG Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Paion AG Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio
  36. 8.6.5 Paion AG Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst